"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...

The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...

The injection is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedur...

With this approval, the company has a total of 14 approvals and 24 under approval ANDAs and is expecting more product approvals during the ...

Sources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst other...

Claris Lifesciences said it has received prior approval supplement (PAS) for Furosemide injection which will help it to resume supply in th...

Income-Tax sleuths today conducted search and survey operations at around 20 commercial and residential premises of Claris Lifesciences, it...

Both sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...

The drug firm said it markets its products through a wholly-owned subsidiary Claris Lifesciences Inc.

Carlyle private equity backed CLL has transferred its speciality injectables business into a wholly owned subsidiary called CIL.

Shareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...

"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."

Ahmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...

Shares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.

Sources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...

Claris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.

Claris Lifesciences’ niche lies in developing cheap injectibles.